SG10201601998PA - Compositions containing lignan-class compounds - Google Patents

Compositions containing lignan-class compounds

Info

Publication number
SG10201601998PA
SG10201601998PA SG10201601998PA SG10201601998PA SG10201601998PA SG 10201601998P A SG10201601998P A SG 10201601998PA SG 10201601998P A SG10201601998P A SG 10201601998PA SG 10201601998P A SG10201601998P A SG 10201601998PA SG 10201601998P A SG10201601998P A SG 10201601998PA
Authority
SG
Singapore
Prior art keywords
compositions containing
class compounds
containing lignan
lignan
class
Prior art date
Application number
SG10201601998PA
Other languages
English (en)
Inventor
Masaaki Nakai
Yukihiro Aoshima
Shuji Endo
Original Assignee
Suntory Holdings Ltd Jp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2006097871A external-priority patent/JP5666760B2/ja
Application filed by Suntory Holdings Ltd Jp filed Critical Suntory Holdings Ltd Jp
Publication of SG10201601998PA publication Critical patent/SG10201601998PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Addiction (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SG10201601998PA 2006-03-31 2007-03-14 Compositions containing lignan-class compounds SG10201601998PA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006097871A JP5666760B2 (ja) 2005-03-31 2006-03-31 リグナン類化合物含有組成物

Publications (1)

Publication Number Publication Date
SG10201601998PA true SG10201601998PA (en) 2016-04-28

Family

ID=38563285

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201601998PA SG10201601998PA (en) 2006-03-31 2007-03-14 Compositions containing lignan-class compounds
SG2011023223A SG172594A1 (en) 2006-03-31 2007-03-14 Compositions containing lignan-class compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2011023223A SG172594A1 (en) 2006-03-31 2007-03-14 Compositions containing lignan-class compounds

Country Status (7)

Country Link
US (1) US9408803B2 (de)
EP (1) EP2002832A4 (de)
KR (1) KR101471677B1 (de)
CN (1) CN101404996B (de)
SG (2) SG10201601998PA (de)
TW (1) TWI434858B (de)
WO (1) WO2007114013A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5059947B2 (ja) 2008-11-06 2012-10-31 日清オイリオグループ株式会社 濃厚流動食
WO2015093484A1 (ja) * 2013-12-16 2015-06-25 サントリーホールディングス株式会社 セサミン類高含有組成物
WO2016152846A1 (ja) * 2015-03-23 2016-09-29 サントリーホールディングス株式会社 概日リズム改善用組成物

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4971127A (de) 1972-11-18 1974-07-10
JPS5492616A (en) 1977-12-28 1979-07-23 Ota Pharma Ubidecalenone soft capsule preparation
DE8026760U1 (de) 1980-10-07 1981-02-12 Segger Kg Industriekoffer - Kunststoffspritzguss, 4446 Hoerstel Haltevorrichtung fuer behaelter an zweiraeder
JPS5820422A (ja) 1981-07-31 1983-02-05 Yushiro Do Brazil Ind Chem Ltd ポリウレタンフオ−ム成形用金型の汚れの除去剤
JPS58156182A (ja) 1982-03-10 1983-09-17 株式会社クボタ 穀物乾燥機の運転制御方法
US4427694A (en) 1982-06-11 1984-01-24 The Vinoxen Company, Inc. Sesamin as a psychotropic agent
JPS5913717A (ja) * 1982-07-16 1984-01-24 Asahi Chem Ind Co Ltd エマルジヨン製剤
DE3307353C2 (de) * 1983-03-02 1985-01-31 R.P. Scherer GmbH, 6930 Eberbach Polyethylenglykolhaltige Weichgelatinekapsel und Verfahren zu ihrer Herstellung
JPS6157400A (ja) 1984-05-19 1986-03-24 ワシ中越ボ−ド株式会社 転写印刷部分と同調した凹凸部を有する印刷化粧材及びその製造方法
FI79682C (fi) 1988-02-02 1990-02-12 Elopak Oy Foerfarande foer toemning av en hopptryckbar last ur en kartonglaoda samt kartonglaoda foer utfoerande av foerfarandet.
JPH02138120A (ja) 1988-11-21 1990-05-28 Nippon Kayaku Co Ltd リポキシゲナーゼ阻害剤
JP3070611B2 (ja) 1989-03-07 2000-07-31 サントリー株式会社 △▲上５▼―不飽和化酵素阻害剤
EP0826369B1 (de) 1989-07-21 2003-06-04 Suntory Limited Therapeutische Anwendung von Dioxabicyclo(3.3.0)oktan-Verbindungen
JP3001589B2 (ja) 1989-07-21 2000-01-24 サントリー株式会社 リグナン類含有飲食物
US5211953A (en) 1989-07-21 1993-05-18 Suntory, Limited Liver function improver
JPH02187397A (ja) 1989-11-30 1990-07-23 Kingujimu:Kk 袋状透明リーフの製造方法
JP3183664B2 (ja) 1990-10-22 2001-07-09 サントリー株式会社 コレステロール及び胆汁酸の代謝阻害剤
JP3124062B2 (ja) 1991-02-08 2001-01-15 サントリー株式会社 悪酔防止剤
JPH05178763A (ja) 1991-02-19 1993-07-20 Nippon Saafuakutanto Kogyo Kk 難溶解性薬物溶解剤組成物
JP3283274B2 (ja) 1991-06-15 2002-05-20 サントリー株式会社 新規組成物
JPH0543458A (ja) 1991-08-09 1993-02-23 Suntory Ltd 乳癌抑制剤
JPH0551388A (ja) 1991-08-23 1993-03-02 Suntory Ltd 過酸化脂質生成抑制剤
JPH05163143A (ja) 1991-12-16 1993-06-29 Nisshin Flour Milling Co Ltd α−トコフェロールビタミンＡ酸エステル含有油性組成物
JPH069381A (ja) 1992-03-26 1994-01-18 Toyo Capsule Kk イブプロフェン含有軟カプセル剤
JPH06227977A (ja) 1993-02-01 1994-08-16 Suntory Ltd 活性酸素消去剤
JPH08268887A (ja) 1995-02-01 1996-10-15 Suntory Ltd 高血圧症又はそれに起因する医学的症状の予防又は改善剤
CN1073825C (zh) 1995-07-04 2001-10-31 三得利公司 二氧杂二环[3.3.0]辛烷衍生物的新用途
JPH10120695A (ja) 1996-10-22 1998-05-12 Bizen Kasei Kk ゴマリグナンの製造法
JPH11269456A (ja) 1998-03-19 1999-10-05 Suntory Ltd 高度不飽和脂肪酸組成物
JP3789699B2 (ja) 1999-11-18 2006-06-28 サントリー株式会社 リグナン系抗酸化剤及びその製造法
US6596762B2 (en) * 2001-05-17 2003-07-22 The Regents Of The University Of Colorado Antioxidant compositions and use for treatment of hepatic steatosis and steatohepatitis
TW200302056A (en) 2002-01-18 2003-08-01 Kaneka Corp Method for stabilizing reduced coenzyme Q10 and composition therefor
US20060247310A1 (en) 2002-03-04 2006-11-02 Hisami Shinohara Body temperature elevating agents
JP4261120B2 (ja) 2002-04-05 2009-04-30 株式会社日本吸収体技術研究所 バイパスチャネル部材を具備する吸収体およびそれを用いた吸収体製品
AU2003231439A1 (en) 2002-05-09 2003-11-11 Chugai Seiyaku Kabushiki Kaisha Photostabilized soft capsule
TW200427410A (en) * 2003-01-24 2004-12-16 Kaneka Corp Processed fat compositions for preventing and improving lifestyle-related diseases
WO2004105749A1 (ja) 2003-05-27 2004-12-09 Suntory Limited 自律神経調節作用を有する組成物およびその使用方法
AU2004257756A1 (en) * 2003-07-10 2005-01-27 Carl A. Forest Foods, beverages, condiments, spices and salad dressings with specialized supplements
TW200536525A (en) 2004-03-31 2005-11-16 Suntory Ltd Adiponectin enhancer
WO2006016682A1 (ja) * 2004-08-09 2006-02-16 Suntory Limited 血管弾力性改善剤およびその使用
AU2005320579B2 (en) 2004-12-28 2011-09-22 Suntory Holdings Limited Sesamin/episesamin compositions
JP4473765B2 (ja) * 2005-03-31 2010-06-02 サントリーホールディングス株式会社 リグナン類化合物を含有する乳飲料
JP5666760B2 (ja) * 2005-03-31 2015-02-12 サントリーホールディングス株式会社 リグナン類化合物含有組成物
KR101327649B1 (ko) 2005-03-31 2013-11-12 산토리 홀딩스 가부시키가이샤 리그난류 화합물 함유 수중 유적형 에멀션 및 그것을함유하는 조성물
TWI406867B (zh) 2005-09-30 2013-09-01 Suntory Holdings Ltd And a method for producing a high content of episesamin
EP1950214B1 (de) 2005-11-08 2014-09-10 Suntory Holdings Limited Verfahren zur aufreinigung von episesamin

Also Published As

Publication number Publication date
EP2002832A2 (de) 2008-12-17
US20090247625A1 (en) 2009-10-01
TWI434858B (zh) 2014-04-21
CN101404996B (zh) 2011-05-18
CN101404996A (zh) 2009-04-08
KR20080108143A (ko) 2008-12-11
US9408803B2 (en) 2016-08-09
KR101471677B1 (ko) 2014-12-10
EP2002832A4 (de) 2009-11-11
SG172594A1 (en) 2011-07-28
TW200806693A (en) 2008-02-01
EP2002832A9 (de) 2009-04-22
WO2007114013A1 (ja) 2007-10-11

Similar Documents

Publication Publication Date Title
GB0624290D0 (en) Novel compositions
EP2040708A4 (de) Quercetinhaltige zusammensetzungen
PL1981357T3 (pl) Kompozycje zawierające ß-karoten
GB0607085D0 (en) Novel compositions
GB0625069D0 (en) Compositions
GB0620279D0 (en) Compositions
IL190321A0 (en) Compositions containing saratin
GB0618657D0 (en) Compositions
EP2034838A4 (de) Neuartige verbindungen
EP1986849A4 (de) Waschechte schwelen unterdrückende zusammensetzungen
EP2032142A4 (de) Neuartige verbindungen
EP1981596A4 (de) Neue verbindungen
GB0603550D0 (en) Novel compounds
GB0620918D0 (en) Compositions
EP1981900A4 (de) Neuartige verbindungen
GB0605462D0 (en) Novel compounds
GB0602900D0 (en) Novel Compounds
EP2044012A4 (de) Silanhaltige zusammensetzungen
SG10201601998PA (en) Compositions containing lignan-class compounds
GB0917779D0 (en) Novel compositions
EP2031965A4 (de) Neuartige verbindungen
GB0601899D0 (en) Compositions
GB0611033D0 (en) Compositions
GB0600483D0 (en) Novel compounds
GB0600411D0 (en) Compositions